Background
==========

Ovarian hyperstimulation syndrome (OHSS) is usually iatrogenic and is a potentially life-threatening complication of ovulation induction. Spontaneous OHSS might occur following high levels of human chorionic gonadotropin (HCG) in normal pregnancy, hypothyroidism, or FSH receptor mutation [@bib1]. Expanding use of ultrasonography facilitates the diagnosis and monitoring of the treatment of this syndrome [@bib2].

We have described this syndrome in a girl virgin with primary autoimmune hypothyroidism in our previous article [@bib3]; we followed her by serial abdominal ultrasound that showed normal ovary size and regression of ovarian cysts after levothyroxine ([l]{.smallcaps}-T~4~) replacement.

Case presentation
=================

A 15-year-old girl presented with abdominal pain and distension for a few months. On examination, she had classical features of hypothyroidism [@bib3]. The abdomen was distended and non-tender with a large palpable mass in the lower abdomen extending to the upper abdomen.

Investigation
=============

Laboratory findings included the following: Hb=11.2 g/dl, Hct=36.2%, MCV=81 fl, MCH=28.2 pg, BUN=13 mg/dl, Cr=0.7 mg/dl, cholesterol=290 mg/dl, and TG=273 mg/dl. Hormonal studies confirmed hypothyroidism: serum TSH \>100 mIU/l, total T~4~=1.8 μg/dl (normal: 4.4--12.5 μg/dl, radioimmunoassay (RIA)), T3RU=31.2% (normal: 25--34.4%), anti-TPO antibody=290 U/ml (normal \<70, ELISA), and prolactin=176 ng/ml (normal: 3--21, RIA) [@bib3]. Abdominal and pelvic ultrasound revealed enlarged ovaries that occupied the whole abdomen and pelvic cavity: right ovary, 150×75×62 mm with a volume of 454 cc; left ovary, 130×70×68 mm with a volume of 340 cc. It also represented multiple thin-walled cysts and mild ascitic fluid. Abdominal and pelvic computed tomography (CT) scan showed these thin-walled cysts with no enhancement.

Treatment
=========

She was started on [l]{.smallcaps}-T~4~ 100 μg/day.

Outcome and follow-up
=====================

On follow-up ultrasound, the size of the ovaries became significantly smaller 6 weeks after [l]{.smallcaps}-T~4~ replacement and became normal with complete resolution of cysts after 4 months ([Figs 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}).

![Imaging findings show bilateral multilobulated ovarian cysts. (A) Abdominal ultrasound and (B) abdominal CT scan [@bib3].](edmcr-2013-130006-g001){#fig1}

![Follow-up abdominal sonography showed significant ovarian volume and cyst regression within 4 months of levothyroxine therapy (A) after 2 months, (B) after 4 months, (C) after 8 months (right ovary), and (D) after 8 months (left ovary).](edmcr-2013-130006-g002){#fig2}

Discussion
==========

A description of OHSS in two members of a family has recently been published [@bib3], but there are a few studies focusing on ovarian volume and cyst regression after [l]{.smallcaps}-T~4~ replacement therapy. Imaging findings in OHSS include multiple, large, and thin-walled cysts and ascitic fluid in severe forms [@bib4]. The exclusion of diagnosis of ovarian cancer is made by ultrasonography and CT scan or magnetic resonance imaging (MRI), which reveals the classical 'spoke wheel' appearance that is characteristic of theca lutein cysts without solid components. Furthermore, the reduction in ovarian volume and regression of detected cysts during close observational management and ultrasonic follow-up can differentiate OHSS from other diagnoses [@bib5].

Here, we described resolution of ovarian cysts and normalization of the size of the ovaries in our patient 4 months after [l]{.smallcaps}-T~4~ administration ([Fig. 3](#fig3){ref-type="fig"}). It is noteworthy that the kinetics of the symptoms are closely related to the life span of corpus luteum. In the absence of pregnancy, symptoms resolve spontaneously with the onset of menses, while in the presence of pregnancy, symptoms start to improve after the sixth week of pregnancy, before HCG peak [@bib1]. However, in OHSS with underlying disease such as hypothyroidism, complicated pregnancies or in the presence of mutated FSH receptor genes, the symptoms have been reported to last longer [@bib6] [@bib7] [@bib8] [@bib9] [@bib10] [@bib11] [@bib12] [@bib13] [@bib14]. Mousavi *et al*. [@bib6] reported normalization of ovarian appearance in ultrasound 6 months after [l]{.smallcaps}-T~4~ replacement therapy. In other studies on hypothyroid patients (with and without pregnancy), considerable regression of cysts was observed after 3 months [@bib7] [@bib8] [@bib9] [@bib10] [@bib11], with an exception that in three case reports patients experienced total regression 3 months after delivery [@bib12] [@bib13] [@bib14] ([Table 1](#tbl1){ref-type="table"}). Rising serum level of endogenous HCG might strengthen the severity of OHSS in pregnant patients and would lead to a more complicated course than patients with hypothyroidism [@bib15].

![Right and left ovarian volume change after levothyroxine replacement. \*Upper digit shows the number of cysts and \*\*lower digit shows the largest diameter of the largest cyst.](edmcr-2013-130006-g003){#fig3}

###### 

Summary of case reports describing patients with OHSS associated with hypothyroidism

  **Reference**                **Age** (years)   **Hypothyroidism**        **Pregnancy**              **FSH receptor mutation**                  **Sonographic report**                                                             **Treatment**            **Follow-up**
  ---------------------------- ----------------- ------------------------- -------------------------- ------------------------------------------ ---------------------------------------------------------------------------------- ------------------------ -----------------------------------------------------------
  Hedayati *et al*. [@bib3]    15                TSH \>100 mIU/l Ab:Neg.   --                         Neg.                                       Enlarged ovaries with multiple ovarian cysts Rt: 150×75×62 Lt: 130×70×68           Levothyroxine (100 μg)   After 4 months: normal ovary size and regression of cysts
                               14.5              TSH=72.5 mIU/l            --                         NA                                         Multiple large cysts with rupture of one cyst Rt: 110×65 Lt: 118×58                Levothyroxine (100 μg)   After 4 months: normal
  Akbay *et al*. [@bib13]      21 (P1)           TSH=8.75 mIU/l Ab:NA      10 weeks HCG=Nl            NA                                         Bilateral multilobulated cystic 130×80 sized ovaries                               Levothyroxine (100 μg)   After 3 months of delivery: normal
                               23 (P2)           TSH=2.16 mIU/l Ab:NA      12 weeks HCG=Nl                                                       Bilateral multilobulated cysts Rt: 13×70 Lt: 110×70                                Levothyroxine (100 μg)   After 2 months of delivery: normal
  Dietrich *et al*. [@bib15]   26 (P1)           Normal                    12 weeks HCG=118 665       Present (D567N)                            Bilateral multicystic ovaries Rt: 140×150 Lt: 120×130                              Conservative             Abortion at 15 weeks
                                                                                                                                                 Enlarged ovaries                                                                                            
                               26 (P2)           TSH=5.51 mIU/l Ab:NA      10 weeks HCG=147 688                                                  Rt: 100×100 Lt: 100×100                                                            Levothyroxine (100 μg)   Normal delivery at term
  Lussiana *et al*. [@bib16]   29                TSH=5.92 mIU/l Ab:NA      22 weeks (with abortion)   Present (with undetermined significance)   Bilateral multiple ovarian cysts Rt: 200×110 Lt: 160×120                           Levothyroxine            After 3 months of abortion: normal ovaries
  Edwards *et al*. [@bib9]     30                TSH=41.7 mIU/l            10 weeks HCG=291 206       NA                                         Enlarged mass                                                                      Levothyroxine            By 22 weeks of gestation: ovarian regression
  Borna *et al*. [@bib12]      30                TSH \>400 mIU/l Ab:NA     20 weeks HCG=Nl            NA                                         Bilateral multilobulated ovarian cysts Rt: 200×160 Lt: 160×100                     Levothyroxine (200 μg)   10 weeks after delivery: normal ovaries
  Sultan *et al*. [@bib11]     12                TSH=1310 mIU/l Ab:Neg.    --                         Neg.                                       Large cystic structure                                                             Levothyroxine            After 3 months: resolution of cysts
  Mousavi *et al*. [@bib6]     26                TSH \>50 mIU/l Ab:NA      --                         NA                                         Bilateral multiseptated ovarian masses Rt: 69×63×96 Lt: 66×63×99                   Levothyroxine (100 μg)   After 6 months: normal ovary size
  Taher *et al*. [@bib10]      22                TSH \>100 mIU/l Ab:NA     --                         NA                                         Bilateral multilobulated ovarian mass with cystic component Rt: 90×120 Lt: 60×40   Levothyroxine (100 μg)   After 3 months: marked reduction
  Corsado *et al*. [@bib7]     25                TSH=210 mIU/l Ab:Neg.     11 weeks HCG=15 890        NA                                         Bilateral multilobulated ovarian cysts Rt: 160×150 Lt: 160×130                     Levothyroxine (100 μg)   By 24 weeks of gestation: normal ovary

Ab, antithyroglobulin/antiperoxidase antibody; Neg, negative; NA, not available; P, pregnancy; HCG, human chorionic gonadotropin (IU/l); Nl, normal (according to gestational age); Rt and Lt, right and left ovaries (mm^2^).

In conclusion, ultrasonography as well as CT scan or MRI assists the diagnosis of OHSS. By serial ultrasound, we observed regression of ovarian cysts and ovarian volume after 4 months whereas in other studies, it is reported to happen in various durations that may be related to the etiology of this syndrome.
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